SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit – Investors With Losses May Seek to Lead the Class Action After Hyperphagia Drug Launch Disruptions – Hagens Berman
SAN FRANCISCO, April 21, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman reminds investors in Soleno Therapeutics, Inc....
Read moreDetails